Technical Analysis for PASG - Passage Bio, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | -3.40% | |
Fell Below 50 DMA | Bearish | -3.40% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | -3.40% | |
Wide Range Bar | Range Expansion | -3.40% | |
Wide Bands | Range Expansion | -3.40% | |
Wide Bands | Range Expansion | -13.51% |
Alert | Time |
---|---|
20 DMA Resistance | about 21 hours ago |
Down 5% | about 21 hours ago |
Down 3% | about 21 hours ago |
Down 2 % | about 21 hours ago |
Down 1% | about 21 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Rare Diseases Central Nervous System Disorders Nervous System Disorders Lipid Storage Disorders Monogenic Medicine Products Gm1 Rare Tadataka Yamada
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Rare Diseases Central Nervous System Disorders Nervous System Disorders Lipid Storage Disorders Monogenic Medicine Products Gm1 Rare Tadataka Yamada
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.79 |
52 Week Low | 0.5751 |
Average Volume | 290,542 |
200-Day Moving Average | 0.97 |
50-Day Moving Average | 1.35 |
20-Day Moving Average | 1.33 |
10-Day Moving Average | 1.42 |
Average True Range | 0.14 |
RSI (14) | 45.05 |
ADX | 18.86 |
+DI | 15.98 |
-DI | 25.13 |
Chandelier Exit (Long, 3 ATRs) | 1.21 |
Chandelier Exit (Short, 3 ATRs) | 1.53 |
Upper Bollinger Bands | 1.57 |
Lower Bollinger Band | 1.09 |
Percent B (%b) | 0.39 |
BandWidth | 35.49 |
MACD Line | 0.02 |
MACD Signal Line | 0.02 |
MACD Histogram | -0.0008 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.47 | ||||
Resistance 3 (R3) | 1.47 | 1.41 | 1.44 | ||
Resistance 2 (R2) | 1.41 | 1.36 | 1.41 | 1.43 | |
Resistance 1 (R1) | 1.35 | 1.33 | 1.31 | 1.34 | 1.42 |
Pivot Point | 1.28 | 1.28 | 1.27 | 1.28 | 1.28 |
Support 1 (S1) | 1.22 | 1.24 | 1.19 | 1.22 | 1.14 |
Support 2 (S2) | 1.16 | 1.20 | 1.16 | 1.13 | |
Support 3 (S3) | 1.09 | 1.16 | 1.12 | ||
Support 4 (S4) | 1.09 |